119 related articles for article (PubMed ID: 21649542)
61. CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.
Schmitz N; Zeynalova S; Nickelsen M; Kansara R; Villa D; Sehn LH; Glass B; Scott DW; Gascoyne RD; Connors JM; Ziepert M; Pfreundschuh M; Loeffler M; Savage KJ
J Clin Oncol; 2016 Sep; 34(26):3150-6. PubMed ID: 27382100
[TBL] [Abstract][Full Text] [Related]
62. Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation.
Jabbour E; Peslin N; Arnaud P; Ferme C; Carde P; Vantelon JM; Bocaccio C; Bourhis JH; Koscielny S; Ribrag V
Leuk Lymphoma; 2005 Jun; 46(6):861-7. PubMed ID: 16019530
[TBL] [Abstract][Full Text] [Related]
63. Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study.
Houillier C; Ghesquières H; Chabrot C; Soussain C; Ahle G; Choquet S; Nicolas-Virelizier E; Bay JO; Vargaftig J; Gaultier C; Touitou V; Martin-Duverneuil N; Cassoux N; Le Garff-Tavernier M; Costopoulos M; Faurie P; Hoang-Xuan K
J Neurooncol; 2017 Jun; 133(2):315-320. PubMed ID: 28432587
[TBL] [Abstract][Full Text] [Related]
64. A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Griffin TC; Weitzman S; Weinstein H; Chang M; Cairo M; Hutchison R; Shiramizu B; Wiley J; Woods D; Barnich M; Gross TG;
Pediatr Blood Cancer; 2009 Feb; 52(2):177-81. PubMed ID: 18816698
[TBL] [Abstract][Full Text] [Related]
65. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
66. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
Gill P; Litzow M; Buckner J; Arndt C; Moynihan T; Christianson T; Ansell S; Galanis E
Cancer; 2008 Apr; 112(8):1805-11. PubMed ID: 18300237
[TBL] [Abstract][Full Text] [Related]
67. Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy.
Korfel A; Thiel E
Leuk Lymphoma; 1998 Aug; 30(5-6):609-17. PubMed ID: 9711923
[TBL] [Abstract][Full Text] [Related]
68. Central nervous system anaplastic large cell lymphoma in an adult: successful treatment with a combination of radiation and chemotherapy.
Carmichael MG
Mil Med; 2007 Jun; 172(6):673-5. PubMed ID: 17615857
[TBL] [Abstract][Full Text] [Related]
69. Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
Renaud L; Bossard JB; Carpentier B; Terriou L; Cambier N; Chanteau G; Escure G; Tilmont R; Barbieux S; Wemeau M; Hieulle J; Boyle EM; Morschhauser F
Eur J Haematol; 2021 Sep; 107(3):370-373. PubMed ID: 34018260
[No Abstract] [Full Text] [Related]
70. Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer/T-cell lymphoma.
Nevel KS; Pentsova E; Daras M
Leuk Lymphoma; 2019 Jul; 60(7):1677-1684. PubMed ID: 30648449
[TBL] [Abstract][Full Text] [Related]
71. Long-term survival of diffuse large B cell lymphoma of the trigeminal region extending to the Meckel's cave treated by CHASER therapy: case report.
Tanaka T; Kato N; Itoh K; Hasegawa Y
Neurol Med Chir (Tokyo); 2014; 54(8):677-80. PubMed ID: 24305022
[TBL] [Abstract][Full Text] [Related]
72. A new therapeutic approach in very refractory diffuse large B-cell lymphoma.
Avilés A; Nambo MJ; Neri N; Cleto S; Silva L
Clin Transl Oncol; 2020 May; 22(5):703-707. PubMed ID: 31359338
[TBL] [Abstract][Full Text] [Related]
73. Combination chemotherapy with ifosfamide and etoposide is effective in the treatment of central nervous system metastasis of childhood neuroblastoma.
Watts RG
Cancer; 1992 Jun; 69(12):3012-4. PubMed ID: 1591695
[TBL] [Abstract][Full Text] [Related]
74. Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy.
Al Feghali KA; Fang P; Gule-Monroe M; Milgrom S; Khoury JD; Gunther JR; Sheu T; Nair R; Ahmed S; Steiner R; Strati P; Shpall EJ; Nieto YL; Hosing C; Nastoupil LJ; Westin JR; Neelapu SS; Fowler N; Flowers C; Pinnix CC; Dabaja BS
Leuk Lymphoma; 2021 Oct; 62(10):2400-2407. PubMed ID: 33942701
[TBL] [Abstract][Full Text] [Related]
75. A Rare Case of Spontaneous Remission and Relapse of a Primary Central Nervous System Lymphoma.
Ramos R; Fernandes JS; Almeida M; Almeida R
Acta Med Port; 2018 Dec; 31(12):777-783. PubMed ID: 30684376
[TBL] [Abstract][Full Text] [Related]
76. Cerebrospinal fluid diffusion of Zevalin after high-activity treatment and stem cell support in a patient affected by diffuse large B-cell non-Hodgkin's lymphoma with central nervous system involvement.
Ferrucci PF; Vanazzi A; Tesoriere G; Ferrari M; Bartolomei M; Rocca P; Cremonesi M; Paganelli G; Martinelli G
Ann Oncol; 2005 Oct; 16(10):1710-1. PubMed ID: 15972281
[No Abstract] [Full Text] [Related]
77. Unusual primary central nervous system T-cell/histiocyte-rich large B-cell lymphoma: a case report.
Toro J; Patiño J; Flórez A; Rivera JS
BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35135790
[TBL] [Abstract][Full Text] [Related]
78. Central nervous system relapse in patients with diffuse large B-cell lymphoma: analysis of incidence and prognostic factors.
Uni M; Kagoya Y; Nannya Y; Nakamura F; Kurokawa M
Leuk Lymphoma; 2015 Jun; 56(6):1869-71. PubMed ID: 25267182
[No Abstract] [Full Text] [Related]
79. Topotecan and ifosfamide systemic chemotherapy for CNS involvement of solid tumors.
Kiewe P; Thiel E; Reinwald M; Korfel A
J Neurooncol; 2011 Jul; 103(3):629-34. PubMed ID: 20941526
[TBL] [Abstract][Full Text] [Related]
80. Salvage therapy for diffuse large-cell lymphoma.
Chabner BA
Blood; 1990 Oct; 76(7):1267-8. PubMed ID: 1698475
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
